Entrada Therapeutics (NASDAQ:TRDA) 公布季度每股收益为$0.03，超过分析师一致预期$(0.67)，超出104.48%。与去年同期$(0.29)的亏损相比，这一增长为110.34%。公司季度销售额为$37.40百万，超过分析师一致预期的$13.12百万，超出185.04%。与去年同期$41.85百万的销售额相比，减少了10.63%。

以上内容来自Benzinga Earnings专栏，原文如下：

Entrada Therapeutics (NASDAQ:TRDA) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.67) by 104.48 percent. This is a 110.34 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $37.40 million which beat the analyst consensus estimate of $13.12 million by 185.04 percent. This is a 10.63 percent decrease over sales of $41.85 million the same period last year.